http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106748892-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53b4d53983adbf56dd0e7d0bf96f8ce5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C335-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C335-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
filingDate 2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7da0df7b9ad2788abd2db5d486a6833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99076d572712e8e1774f379720b69886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314af53f9b56ebdd3260da47f71130f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_831e851d71a44395aa388f07e35593ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1de18f1b74ee26d47c5b4911f262c82d
publicationDate 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106748892-A
titleOfInvention Targeted autophagy agonists and their application in the treatment of neurodegenerative diseases
abstract The invention relates to a targeted autophagy agonist and its application in drugs for treating neurodegenerative diseases, and belongs to the technical field of anti-neurodegenerative diseases pharmacy. The technical problem solved by the present invention is to provide a compound as ULK1 agonist. The compound includes the compounds shown below or pharmaceutically acceptable salts thereof. The compound of the present invention or a pharmaceutically acceptable salt thereof can be used as a ULK1 agonist, and has certain activity against neurodegenerative diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112057442-A
priorityDate 2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004022534-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004077635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004022528-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104860924-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID173415
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468295067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431023570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408227550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88998982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146014432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421814225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467921364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466462955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412021512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466136473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468347723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407632194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145965460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421252626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424671400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53409138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412603822

Total number of triples: 50.